Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 4, 2009, Pages 619-622

  He, Yutong ^a   Ye, Li ^a   Shan, Baoen ^a   Song, Guohui ^b   Meng, Fanshu ^b   Wang, Shijie ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Cixian Cancer Institute   (China)

Author keywords

Esophageal SCC; Fortified salt; High incidence area; Intervention; Riboflavin

Indexed keywords

EID: 77951098515     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bessey OA, Horeitt MK, Love RH (1956). Dietary deprivation of riboflavin and blood riboflavin levels in man. J Nutr, 58, 367-83.
2. Chang-Claude J, Shimada H, Muñoz N, et al (1992). Micronuclei in esophageal cells of Chinese youths in a high-incidence area for esophageal cancer in China. Cancer Epidemiol Biomarkers Prev, 1, 463-6.
3. Chen H, Tucker KL, Graabard BI, et al (2002). Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer, 42, 33-40.
4. Cui J, Luo X (2006). The riboflavin and cancer prevention. Cancer Res Prev Treat, 33, 543-4.
5. Foy H, Kondi A (1984). The vulnerable oesophagus: riboflavin deficiency and squamous cell dysplasia of the skin and the oesophagus. J Natl Cancer Inst, 72, 941-8.
6. He Y, Hou J, Chen Z, et al (2008). Trends in incidence of the esophageal and gastric cardia cancer in high-risk areas, China. Eur J Cancer Prev, 17, 71-6.
7. Landommenica ARG, Dizdaroglu M, Halliwell B, et al (1997). The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide. Free Radical Biol Med, 23, 426-34.
8. Lu XJ, Chen ZF, Guo CL (2004). Endoscopic survey of esophageal cancer in a high-risk area of China. World J Gastroenterol, 10, 2931-5.
9. Mattson MP, Kruman II, Duan W (2002). Folic acid and homocysteine in age-related disease. Ageing Res Rev, 1, 95-111.
10. Pangrekar L, Krishnasuamy K, Jagadeesan V (1993). Effect of riboflavin deficiency and riboflavin administration on carcinogen DNA binding. Food Chem Toxicol, 31, 745-50.
11. Sauberlich HE, Judd JH, Jun, et al (1972). Application of the erythrocyte glutathione reductase assay in evaluating riboflavin nutritional status in high school student population. Am J Clin Nutr, 25, 756-62.
12. Siassi F, Ghadirian P (2005). Riboflavin deficiency and esophageal cancer: A case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev, 29, 419-26.
13. Taylor PR, Wang G-Q, Dawsey SM, et al (1995). Effect of nutrition intervention on intermediate endpoints in esophageal and gastric carcinogenesis. Am J Clin Nutr, 62 (suppl), 1420s-3s.
14. Van Rensburg SJ (1981). Epidemiological and dietary evidence for a specific nutritional predisposition to esophageal cancer. J Natl Cancer Inst, 67, 243-51.
15. Wang G-Q, Zhou M-H, Cong Q-W (1995). Lugol's solution in endoscopic diagnosis of early esophageal cancer. Zhonghua Yixue Zazhi, 75, 417-8.
16. Webster RP, Gawde MD, Bhattacharya RK (1996). Modulation ofcarcinogen-induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett, 98, 129-35.